These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 9776272

  • 21. Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates.
    Innis RB, Malison RT, al-Tikriti M, Hoffer PB, Sybirska EH, Seibyl JP, Zoghbi SS, Baldwin RM, Laruelle M, Smith EO.
    Synapse; 1992 Mar; 10(3):177-84. PubMed ID: 1532675
    [Abstract] [Full Text] [Related]

  • 22. Estimation of dopamine D2 receptor binding potential in the striatum with iodine-123-IBZM SPECT: technical and interobserver variability.
    Verhoeff NP, Kapucu O, Sokole-Busemann E, van Royen EA, Janssen AG.
    J Nucl Med; 1993 Dec; 34(12):2076-84. PubMed ID: 8254390
    [Abstract] [Full Text] [Related]

  • 23. Imaging of dopamine receptors with [123I]iodobenzamide single-photon emission-computed tomography in neuroleptic malignant syndrome.
    Jauss M, Krack P, Franz M, Klett R, Bauer R, Gallhofer B, Dorndorf W.
    Mov Disord; 1996 Nov; 11(6):726-8. PubMed ID: 8914102
    [Abstract] [Full Text] [Related]

  • 24. In vitro and in vivo D2-dopamine receptor binding with [123I]S(-) iodobenzamide ([123I]IBZM) in rat and human brain.
    Verhoeff NP, Bobeldijk M, Feenstra MG, Boer GJ, Maas MA, Erdtsieck-Ernste E, de Bruin K, van Royen EA.
    Int J Rad Appl Instrum B; 1991 Nov; 18(8):837-46. PubMed ID: 1839302
    [Abstract] [Full Text] [Related]

  • 25. Test-retest reproducibility of extrastriatal dopamine D2 receptor imaging with [123I]epidepride SPECT in humans.
    Varrone A, Fujita M, Verhoeff NP, Zoghbi SS, Baldwin RM, Rajeevan N, Charney DS, Seibyl JP, Innis RB.
    J Nucl Med; 2000 Aug; 41(8):1343-51. PubMed ID: 10945525
    [Abstract] [Full Text] [Related]

  • 26. [123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics.
    Klemm E, Grünwald F, Kasper S, Menzel C, Broich K, Danos P, Reichmann K, Krappel C, Rieker O, Briele B, Hotze AL, Möller HJ, Biersack HJ.
    Am J Psychiatry; 1996 Feb; 153(2):183-90. PubMed ID: 8561197
    [Abstract] [Full Text] [Related]

  • 27. [The determination of cerebral dopamine (D2) receptor density by using 123I-IBZM-SPECT in Parkinson disease patients].
    Hierholzer J, Cordes M, Schelosky L, Barzen G, Poewe W, Henkes H, Keske U, Horowski R, Felix R.
    Rofo; 1992 Oct; 157(4):390-8. PubMed ID: 1391843
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Initial experience with SPECT examinations using [123I]IBZM as a D2-dopamine receptor antagonist in Parkinson's disease.
    Cordes M, Henkes H, Laudahn D, Bräu H, Kramp W, Girke W, Hierholzer J, Eichstädt H, Felix R.
    Eur J Radiol; 1991 Oct; 12(3):182-6. PubMed ID: 1830273
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Simultaneous 99mTc and 123I dual-isotope brain striatal phantom single photon emission computed tomography: validation of 99mTc-TRODAT-1 and 123I-IBZM simultaneous dopamine system brain imaging.
    Kao PF, Wey SP, Yang AS.
    Kaohsiung J Med Sci; 2009 Nov; 25(11):601-7. PubMed ID: 19858039
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT.
    Pirker W, Riedl M, Luger A, Czech T, Rössler K, Asenbaum S, Angelberger P, Kornhuber J, Deecke L, Podreka I, Brücke T.
    J Nucl Med; 1996 Dec; 37(12):1931-7. PubMed ID: 8970508
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Steele-Richardson-Olszewski-syndrome: reduction of dopamine D2 receptor binding relates to the severity of midbrain atrophy in vivo: (123)IBZM SPECT and MRI study.
    Arnold G, Tatsch K, Kraft E, Oertel WH, Schwarz J.
    Mov Disord; 2002 May; 17(3):557-62. PubMed ID: 12112207
    [Abstract] [Full Text] [Related]

  • 39. Effect of haloperidol dose on iodine-123-IBZM brain SPECT imaging in schizophrenic patients.
    Vallabhajosula S, Hirschowitz J, Machac J.
    J Nucl Med; 1997 Feb; 38(2):203-7. PubMed ID: 9025736
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.